Fritextsökning
Innehållstyper
-
Cancer cells cheat suicide call
Cancer cells cheat death by reversing a process which causes normal cells to commit suicide at the end of their natural life, researchers from the University of...
-
Per Hammargren, Sales Director, ICU Scandinavia AB
Why are you going to Scanlab and Biotech Forum?
-
Recipharm launches into biologics manufacturing
Recently a Swedish biomanufacturing facility transfers from Astrazeneca to Recipharm Biologics.
-
Nya resultat om immunförsvarets reaktion vid svår covid-19
Forskare har identifierat flera celltyper som är centrala vid immunförsvarets reaktion vid covid-19.
-
New firm based on SLU research
Four researchers at the Swedish University of Agricultural Sciences, SLU, has recently founded a new nanotech company.
-
Pfizer överväger nya bud
Obama-administrationens nya skatteregler hämmar inte bolagets köplust.
-
New nano professor in Denmark
The Technical University of Denmark has appointed a recognized physicist as a new professor of miniaturized sensors.
-
Varnar för Astra-preparat
FDA går ut med ännu en varning för läkemedelsklassen SGLT2-hämmare.
-
Inga svenska företag i topp 50
Varje år sammanställer Boston Consulting Group en lista över världens 50 mest innovativa företag. Inga svenska företag finns representerade på årets lista som toppas av Apple – men en rad internationella life sciencebolag är med....
-
Lytix calls in cash
Norwegian company Lytix Biopharma closes a USD 1.4 million funding round to finance new antimicrobial and oncology lead compounds.
-
How to get the most out of the fair
-
Ten recieve the Venture Cup West Prize
At this year´s Venture Cup West awards the 10 best business ideas in Venture Cup West 08/09 were chosen, receiving SEK 10 000 each.
-
L och MP backar i flera regioner
-
Swedish top scientists to EMBO
Two Swedish top scientists will have a really good chance to influence European life science research from now on. One is from the Karolinska Institutet, and on...
-
New CEO to Promedvi
Sigrun Axelsson has taken on the leadership of the Lund-based medtech company.
-
New NO product reduces diabetic pain
The Swedish medtech company Nolabs has announced that it has achieved an important milestone in the development of a new line of products.
-
Lundbeck divests companies
The company sells all shares in one listed company plus divests four small private equity funds, for a three-figured million sum.
-
Enjoy Stockholm - the capital of Scandinavia
Welcome to Stockholm! Built on 14 islands, you are never far from the water in the capital of Sweden. Stockholm offers a wide range of museums, theaters, and at...
-
Success fee to Bioinvent and partner
The cancer collaboration started last year. After successful technology transfer the two partner companies now receives 5 million euro from pharma giant Roche.
-
Analytisk kemi nytt ben för Recipharm
CDMO Recipharm lanserar en fristående tjänst inom analytisk kemi.
-
Definite answer with new cancerous gene
A newly discovered cancer gene is enabling the diagnosis of adenoid cystic caranoima using a genetic test.
-
Ny glaskeram för tandlagning
Forskare på Ångströmlaboratoriet vid Uppsala universitet har tagit fram glaskeramer lämpliga som tandlagningsmaterial, som är tre gånger starkare än befintliga.
-
DKK 1,3 billion for grand research
Danish Councils for Independent Research, DFF, will grant DKK 1,3 billion during 2009. Now has the application period started.
-
Kraftigt ökad läkemedelförsäljning – här är bolagen som sålde mest
Fjolåret bjöd på en kraftig försäljningsökning i Sverige för de största läkemedelsföretagen. Åtta av tio företag på tio i topp-listan ökade med mer än tio proce...